Target intelligence / Profile preview

T cell receptor beta joining 2-2 pseudogene (TRBJ2-2P)

Target
TRBJ2-2P
Molecular classification
Pseudogene, Immunoglobulin superfamily (non-functional segment)
01

Overview

T cell receptor beta joining 2-2P (TRBJ2-2P) is a non-functional, pseudogene segment within the cluster of joining (J) region gene segments on the T cell receptor beta (TRB) locus. The T cell receptor beta chain is a component of the αβ T cell receptor, which is critical for antigen recognition by T lymphocytes. However, as a pseudogene, TRBJ2-2P does not give rise to a functional joining sequence or contribute to the diversity of the β chain. It does not produce a protein product and has no known physiological or pathological roles. The T cell receptor beta chain is generated by recombination of variable (V), diversity (D), and joining (J) gene segments, but pseudogenes such as TRBJ2-2P are non-functional and not included in mature, expressed receptors. TRBJ2-2P may be annotated in bioinformatics or genomics databases, but is of research interest only for mapping, evolutionary, or diversity studies—not for therapeutic intervention or disease association. Unlike genuine TCRB J segments, it provides no signal transduction, immune function, or disease relevance. In summary, TRBJ2-2P is a pseudogene in the TCR β locus with no protein product, molecular function, or disease relevance, and is not a drug target.

Other names
TRBJ2-2PTRBJ22PT cell receptor beta joining 2-2P pseudogene

Beyond the preview

Go deeper on T cell receptor beta joining 2-2 pseudogene (TRBJ2-2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta joining 2-2 pseudogene (TRBJ2-2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call